Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung TrialSolange Peters, Egbert F. Smit, Rolf A. Stahel et al.|Journal of Thoracic Oncology|2016Cited by 22
Sixteenth sir peter freyer memorial lecture and surgical symposium September 13th & 14th, 1991 Session IJohn M. Coulter, Peyton Murphy, W. O. Kirwan et al.|Irish Journal of Medical Science (1971 -)|1992Cited by 0